Annexon, Inc. (ANNX)
5.565
+0.14
(+2.68%)
USD |
NASDAQ |
Jun 01, 16:00
5.565
0.00 (0.00%)
After-Hours: 20:00
Annexon EPS Diluted (Quarterly) : -0.2273 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1646 |
| Immix Biopharma, Inc. | -0.1822 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.14M |
| Total Expenses (Quarterly) | 44.14M |
| Enterprise Value | 688.44M |
| Earnings Yield | -21.85% |
| Normalized Earnings Yield | -21.85 |